TCF21 functions as a tumor suppressor in colorectal cancer through inactivation of PI3K/AKT signaling.

Dai, Youyi; Duan, Huaxin; Duan, Chaojun; Zhu, Hong; Zhou, Rongrong; Pei, Haiping; Shen, Liangfang

Dai, Youyi; Duan, Huaxin; Duan, Chaojun; Zhu, Hong; Zhou, Rongrong; Pei, Haiping; Shen, Liangfang.

Afiliación

Dai Y; Department of Oncology, Xiangya Hospital, Central South University.
Duan H; Department of Oncology, Hunan Provincial People's Hospital; Department of Oncology, The First Affiliated Hospital of Hunan Normal University.
Duan C; Institute of Medical Sciences, Xiangya Hospital, Central South University.
Zhu H; Department of Oncology, Xiangya Hospital, Central South University.
Zhou R; Department of Oncology, Xiangya Hospital, Central South University.
Pei H; Department of General Surgery, Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China.
Shen L; Department of Oncology, Xiangya Hospital, Central South University.

Onco Targets Ther ; 10: 1603-1611, 2017.

Article en En | MEDLINE | ID: mdl-28352192

Palabras clave

MMPs; PI3K/AKT signaling; TCF21; colorectal cancer; prognosis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Onco Targets Ther Año: 2017 Tipo del documento: Article Pais de publicación: Nueva Zelanda

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google